FDA Approves ATROPINE SULFATE — Lifestar Pharma LLC
The FDA has granted approval to Lifestar Pharma LLC’s ANDA for Atropine Sulfate Ophthalmic Solution, a generic alternative to branded versions used for myopia control. The approval is anticipated to leverage price discounting to intensify competitive pressure within the myopia management eye-drop market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day